Mark Allen Hadd

Title: The Innovative Contributions of Mark Allen Hadd

Introduction

Mark Allen Hadd is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating various disorders. With a total of seven patents to his name, Hadd's work is recognized for its potential impact on medical treatments.

Latest Patents

Hadd's latest patents include the crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid (Compound 1) for use in S1Preceptor-associated disorders. This invention relates to a novel crystalline free-plate habit or morphology, processes for preparing this crystalline form, and its applications in treating various conditions. These conditions include diseases mediated by lymphocytes, transplant rejection, autoimmune diseases, inflammatory diseases, cancer, and disorders associated with vascular integrity and angiogenesis.

Career Highlights

Throughout his career, Mark Allen Hadd has worked with notable companies, including Arena Pharmaceuticals, Inc. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues. His contributions have been instrumental in advancing research and development in the field.

Collaborations

Hadd has collaborated with several professionals in his field, including Ryan O Castro and Anthony C Blackburn. These collaborations have fostered a productive environment for innovation and have led to the successful development of his patented inventions.

Conclusion

Mark Allen Hadd's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes. His contributions continue to influence the field and pave the way for future advancements.